Oracle must wait for poison pill decision
261838
Oracle&#39;s proposed takeover of Peoplesoft has hit another barrier. A Delaware judge has delayed his final ruling over Peoplesoft&#39;s poison pill defence, saying that he needs to hear more evidence.
659522
In the final days before shareholders decide on Oracle&#39;s takeover bid for rival software maker PeopleSoft (PSFT), Oracle (ORCL) is scrambling for votes, and PeopleSoft is bracing for the worst.
366403
Oracle Corp. on Monday said it has asked Peoplesoft Inc.'s board of directors to immediately redeem the company's poison pill, two days after 61 percent of PeopleSoft shareholders tendered their stock for Oracle's &#36;24-a-share hostile offer.
202859
Oracle Corp. on Monday again asked PeopleSoft Inc.'s board of directors to rescind an anti-takeover provision, as the two business software makers prepared to return to court this week to address one of the final barriers to the &#36;9.2-billion takeover bid.
459877
Oracle Corp. on Monday said it asked  Peoplesoft Inc.'s board of directors to immediately rescind a  "poison pill" anti-takeover provision, two days after 61  percent of PeopleSoft shareholders tendered their stock in  favor of Oracle's $24-a-share hostile offer.
759864
Says certain documents, which Oracle and others want to keep from eyes of rivals, may be necessary to decide case.
35389
A battle between rival shareholder groups is brewing in advance of Friday&#39;s final deadline for tendering shares to Oracle in support of its $9bn hostile takeover bid for rival PeopleSoft.
367582
U.S. regulators on Friday delayed a decision on whether to approve over-the-counter sales of a Barr Pharmaceuticals "morning-after pill" to prevent pregnancy, prompting a lawsuit from a women's rights group.
162521
NEW YORK - While Oracle Corp. awaits a judge's decision on whether it can continue in its quest to acquire PeopleSoft Inc., the company faced a setback in an unrelated case. An appeals court on Wednesday ruled that a three-year-old shareholder lawsuit charging Oracle and several of its top executives with misleading investors about Oracle's performance may proceed, overturning a lower court's dismissal.
264296
The company&#39;s initial offer of $7.7bn or $21 per share, was due to expire at midnight tonight but Peoplesoft will now have another two weeks, until 22 October, to make their decision.
695798
Yet another delay from the FDA leaves investors hanging.
393495
European antitrust regulators are set to announce Tuesday whether they will block Oracle&#39;s hostile takeover bid for rival PeopleSoft.
641682
A source close to the case says a ruling in Justice Dept.'s antitrust suit to stop Oracle from acquiring PeopleSoft may come this week.
672526
Merck & Co. MRK.N said on Friday it   would delay seeking approval for a combination pill designed to   lower "bad" cholesterol, increase "good" cholesterol and avoid   a common side effect of one of the ingredients.
228971
The two companies are waiting for a hearing in Delaware next week when a judge will hear evidence from PeopleSoft regarding why its board rejected Oracle&#39;s latest bid of $24 a share.
454551
Takeover battle likely to drag on as Oracle faces other obstacles in merger quest.
97148
Thursday&#39;s pro-Oracle Corp. decision on the US Department of Justice&#39;s attempt to block Oracle&#39;s proposed takeover of PeopleSoft Inc.